WCM
BMY icon

Westend Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Westend Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.2K Hold
611
– – 0.01% 112
2026
Q1 		$37.1K Sell
611
-57
-9% -$3.32K 0.01% 104
2025
Q4 		$36K Hold
668
– – 0.01% 102
2025
Q3 		$30.1K Hold
668
– – 0.01% 90
2025
Q2 		$30.9K Hold
668
– – 0.01% 90
2025
Q1 		$40.7K Hold
668
– – 0.02% 81
2024
Q4 		$37.8K Buy
+668
New +$37.3K 0.01% 84

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Westend Capital Management's BMY Position: Q2 2026 in Review

Westend Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 611 shares worth $35.2K. The position accounts for 0.01% of the portfolio, ranked #112.

Westend Capital Management first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $40.7K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Westend Capital Management held 611 shares of Bristol-Myers Squibb worth $35.2K as of Q2 2026.
  • Westend Capital Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Westend Capital Management's portfolio in Q2 2026, its #112 holding.
  • Westend Capital Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Westend Capital Management's Bristol-Myers Squibb position peaked at $40.7K in Q1 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Westend Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.